How severe is CVE-2020-5017?

CVE-2020-5017 has a CVSS 3.x base score of 5.5, rated medium severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.

Is CVE-2020-5017 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (20th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2020-5017?

CVE-2020-5017 affects Ibm Spectrum Protect. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2020-5017?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2020-5017 published?

CVE-2020-5017 was published on 2021-01-08 and last updated on 2026-06-17.

CVE-2020-5017

CVE-2020-5017 is a medium-severity vulnerability in Ibm Spectrum Protect with a CVSS 3.x base score of 5.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Severity: Medium (CVSS 3.x base score 5.5)
CVSS v2: 2.1
EPSS exploit prediction: 0% (20th percentile)
Actively exploited: Not listed in CISA KEV
Affected product: Ibm Spectrum Protect
Published: 2021-01-08
Last modified: 2026-06-17

Description

IBM Spectrum Protect Plus 10.1.0 through 10.1.6 may allow a local user to obtain access to information beyond their intended role and permissions. IBM X-Force ID: 193653.

Frequently asked questions

What is CVE-2020-5017?: IBM Spectrum Protect Plus 10.1.0 through 10.1.6 may allow a local user to obtain access to information beyond their intended role and permissions. IBM X-Force ID: 193653.
How severe is CVE-2020-5017?: CVE-2020-5017 has a CVSS 3.x base score of 5.5, rated medium severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2020-5017 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (20th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2020-5017?: CVE-2020-5017 affects Ibm Spectrum Protect. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2020-5017?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2020-5017 published?: CVE-2020-5017 was published on 2021-01-08 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:ibm:spectrum_protect:*:*:*:*:*:*:*:*

More vulnerabilities in Ibm Spectrum Protect

CVE-2020-4415 — Critical (CVSS 9.8): IBM Spectrum Protect 7.1 and 8.1 server is vulnerable to a stack-based buffer overflow, caused by improper bounds…
CVE-2020-4222 — Critical (CVSS 9.8): IBM Spectrum Protect Plus 10.1.0 and 10.1.5 could allow a remote attacker to execute arbitrary code on the system. By…
CVE-2020-4213 — Critical (CVSS 9.8): IBM Spectrum Protect Plus 10.1.0 and 10.1.5 could allow a remote attacker to execute arbitrary code on the system. By…
CVE-2020-4212 — Critical (CVSS 9.8): IBM Spectrum Protect Plus 10.1.0 and 10.1.5 could allow a remote attacker to execute arbitrary code on the system. By…
CVE-2020-4211 — Critical (CVSS 9.8): IBM Spectrum Protect Plus 10.1.0 and 10.1.5 could allow a remote attacker to execute arbitrary code on the system. By…
CVE-2020-4210 — Critical (CVSS 9.8): IBM Spectrum Protect Plus 10.1.0 and 10.1.5 could allow a remote attacker to execute arbitrary code on the system. By…

All CVEs affecting Ibm Spectrum Protect →